Redhill Biopharma
RDHL
#10410
Rank
โ‚น0.51 B
Marketcap
โ‚น101.33
Share price
-2.61%
Change (1 day)
-80.18%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น63,331. In 2017 the company made an earnings per share (EPS) of -โ‚น2,26,181 a decrease over its 2016 EPS that were of -โ‚น1,99,040.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,26,18113.64%
2016-โ‚น1,99,0409.12%
2015-โ‚น1,82,40168.01%
2014-โ‚น1,08,567-25.93%
2013-โ‚น1,46,565

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น335.26-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น687.03-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น325.33-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น57.00-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น110.38-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel